GENE ONLINE|News &
Opinion
Blog

Feature
COVID-19
Novavax’s COVID-19 Vaccine is Safe and Immunogenic in Early Trial
2020-08-06
In-Depth
Spotlight: New Gene Therapies on the Horizon for the Treatment of Neurogenetic Diseases
2020-08-03
Technology Cas9
CRISPR C-to-G Base Editors: A Therapeutic Promise
2020-07-31
COVID-19 IONIC Trial
COVID-19: Immunic, Inc. Begins Phase 2 Trial of IMU-838 in fusion with Oseltamivir
2020-07-30
Interviews National Health Research Institutes
Building a Biomedical Value Chain and Accelerating the Development of the Biomedical Industry
2020-07-29Partner
COVID-19
COVID-19 Vaccine: Moderna Begins Phase 3 COVE Study of mRNA-1273
2020-07-27
Asia-Pacific BIO Asia-Taiwan
The Rise of Asia as a Destination of Biotech Investment and Opportunity
2020-07-27Partner
Innovative Diagnostics, AI, Blockchain and Telemedicine Boosts COVID-19 Fight
2020-07-26Partner
COVID-19 Taiwan
Efforts Behind the Taiwan Model of Combating COVID-19 Pandemic
2020-07-26Partner
Deals
A New Paradigm in Biotech Innovation and Investment
2020-07-24Partner
Part I Highlights of BIO Asia-Taiwan 2020 (Day 1): The Effect of COVID-19 on Global Biotech Industry
2020-07-22Partner
Interviews Cancer
The Profound Impact of Duplex Sequencing: An Interview with Jesse Salk, CEO, TwinStrand Biosciences
2020-07-20
COVID-19
COVID-19: AstraZeneca and University of Oxford’s Vaccine Candidate Shows Promise in Early Human Trials
2020-07-20
COVID-19
COVID-19: Medicago Begins Phase I Trials for Plant-Based VLP Vaccine
2020-07-19
COVID-19
Pfizer & BioNTech’s COVID-19 Vaccine Receives FDA’s Fast Track Designation
2020-07-15
1 … 48 49 50 51 52 … 60
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top